Literature DB >> 8529448

[Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis].

J Scheele1, R Stangl, K Schmidt, A Altendorf-Hofmann.   

Abstract

In the period 1960 to 1992 a total of 366 patients underwent macroscopic and histologic complete resection (R0) of colorectal liver metastases. Excluding 16 operative deaths and 4 patients with incomplete follow-up information, 346 patients form the basis for this report. Of them, 240 (69.4%) developed recurrent disease involving the liver in 136 (39.3%) instances. 71 patients underwent a tumor related reoperation with a re-resection performed in 60 cases. This involved the liver in 22 patients. 47 of these procedures (19.6% of all recurrences), and 16 re-resections of the liver (11.8% of hepatic recurrences) were ultimately classified R0. Additional 9 patients who had the initial liver resection performed in other hospitals underwent hepatic re-resection which was classified R0 in 8. Out of 8 subsequent reoperations, 3 addressed the liver. Operative mortality in the 34 re-resections at the liver was 2.9% while nonlethal morbidity was 17.7%. After a minimum and median follow-up time of 18 and 49 months, resp., 27 patients are alive without recurrent disease, including 11 patients with hepatic re-resection. Another 4 patients are alive with disease, one of them after repeat liver resection. 5-year survival from re-resection is 39.0% for the entire group of 55 R0-patients, and 45.6% for the 24 who underwent hepatic R0-re-resection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8529448

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  8 in total

Review 1.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 2.  Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?

Authors:  Khurum Khan; Anita Wale; Gina Brown; Ian Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Extended resections of liver metastases from colorectal cancer.

Authors:  S Jonas; A Thelen; C Benckert; A Spinelli; S Sammain; U Neumann; B Rudolph; P Neuhaus
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections.

Authors:  Elie Chouillard; Daniel Cherqui; Claude Tayar; Francesco Brunetti; Pierre-Louis Fagniez
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

Review 5.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 6.  A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.

Authors:  Vincent W T Lam; Tony Pang; Jerome M Laurence; Emma Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson
Journal:  J Gastrointest Surg       Date:  2013-03-23       Impact factor: 3.452

7.  [Current concepts and recent developments of laser ablation in tumor therapy].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; R Puls; N Hosten; U Speck; J Ricke; H Oettle; P Hohenberger; R Felix
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

8.  Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?

Authors:  Thiery Chapelle; Bart Op De Beeck; Ivan Huyghe; Sven Francque; Ann Driessen; Geert Roeyen; Dirk Ysebaert; Kathleen De Greef
Journal:  HPB (Oxford)       Date:  2016-03-21       Impact factor: 3.647

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.